(2023). Healthcare resource utilisation and cost of pneumococcal disease from 2003 to 2019 in children ≤17 years in England. Plos One, 18, e0283084. http://doi.org/10.1371/journal.pone.0283084
. Humans
(2023). External validation of the QLifetime cardiovascular risk prediction tool: population cohort study. Bmc Cardiovasc Disord, 23, 194. http://doi.org/10.1186/s12872-023-03209-8
. (2023). Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data. Bmc Nephrol, 24, 91. http://doi.org/10.1186/s12882-023-03119-z
. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295
. (2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. Bmj Open, 13, e070985. http://doi.org/10.1136/bmjopen-2022-070985
. (2023). A machine learning approach to support triaging of primary versus secondary headache patients using complete blood count. Plos One, 18, e0282237. http://doi.org/10.1371/journal.pone.0282237
. (2023). Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink. Bmj Open, 13, e065927. http://doi.org/10.1136/bmjopen-2022-065927
. (2023). Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data. Plos One, 18, e0282513. http://doi.org/10.1371/journal.pone.0282513
. (2023). Socioeconomic gradient in mortality of working age and older adults with multiple long-term conditions in England and Ontario, Canada. Bmc Public Health, 23, 472. http://doi.org/10.1186/s12889-023-15370-y
. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231-245. http://doi.org/10.2147/copd.s389281
.